A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies

References

• Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol. 2011;21(5):576–13. https://doi.org/10.1016/j.sbi.2011.08.005.
   PubMed Web of Science ®Google Scholar
• Boune S, Hu P, Epstein AL, Khawli LA. Principles of N-Linked glycosylation variations of IgG-based therapeutics: pharmacokinetic and functional considerations. Antibodies. 2020;9(2):22. doi:10.3390/antib9020022.
   Web of Science ®Google Scholar
• Ghaderi D, Taylor RE, Padler-Karavani V, Diaz S, Varki A. Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat Biotechnol. 2010;28:863–67. doi:10.1038/nbt.1651.
   PubMed Web of Science ®Google Scholar
• Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev. 2012;28(1):147–75. PMID: 22616486. doi: 10.5661/bger-28-147.
   PubMed Web of Science ®Google Scholar
• Mao L, Schneider JW, Robinson AS. Progress toward rapid, at-line N-glycosylation detection and control for recombinant protein expression. Curr Opin Biotechnol. 2022;78:102788. doi:10.1016/j.copbio.2022.102788.
   PubMed Web of Science ®Google Scholar
• Kaur H. Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development. Crit Rev Biotechnol. 2021;41(2):300–15. doi:10.1080/07388551.2020.1869684.
   PubMed Web of Science ®Google Scholar
• Hilliard M, Alley WR, McManus CA, Yu YQ, Hallinan S, Gebler J, Rudd PM. Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: from sample preparation to data analysis. MAbs. 2017;9(8):1349–59. doi:10.1080/19420862.2017.1377381.
   PubMed Web of Science ®Google Scholar
• Jensen PH, Karlsson NG, Kolarich D, Packer NH. Structural analysis of N- and O-glycans released from glycoproteins. Nat Protoc. 2012;7:1299–310. doi:10.1038/nprot.2012.063.
   PubMed Web of Science ®Google Scholar
• Duivelshof BL, Jiskoot W, Beck A, Veuthey J-L, Guillarme D, D’Atri V. Glycosylation of biosimilars: recent advances in analytical characterization and clinical implications. Anal Chim Acta. 2019;1089:1–18. doi:10.1016/j.aca.2019.08.044.
   PubMed Web of Science ®Google Scholar
• Hirabayashi J, Yamada M, Kuno A, Tateno H. Lectin microarrays: concept, principle and applications. Chem Soc Rev. 2013;42:4443–58. doi:10.1039/C3CS35419A.
   PubMed Web of Science ®Google Scholar
• Zhang L, Luo S, Zhang B. Glycan analysis of therapeutic glycoproteins. MAbs. 2016;8(2):205–15. PMID: 26599345. doi:10.1080/19420862.2015.1117719.
   PubMed Web of Science ®Google Scholar
• Dang K, Zhang W, Jiang S, Lin X, Qian A. Application of lectin microarrays for biomarker discovery. ChemistryOpen. 2020;9(3):285–300. PMID: 32154049. doi:10.1002/open.201900326.
   PubMed Web of Science ®Google Scholar
• Hirayama M, Shibata H, Imamura K, Sakaguchi T, Hori K. High-mannose specific lectin and its recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a potent anti-HIV activity through high-affinity binding to the viral envelope glycoprotein gp120. Mar Biotechnol. 2016;18(2):215–31. doi:10.1007/s10126-015-9684-2.
   PubMed Web of Science ®Google Scholar
• Wallner J, Sissolak B, Sommeregger W, Lingg N, Striedner G, Vorauer-Uhl K. Lectin bio-layer interferometry for assessing product quality of fc- glycosylated immunoglobulin G. Biotechnol Prog. 2019;35:e2864. PMID: 31180180. doi:10.1002/btpr.2864.
   PubMed Web of Science ®Google Scholar
• Kuno A, Uchiyama N, Koseki-Kuno S, Ebe Y, Takashima S, Yamada M, Hirabayashi J. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat Methods. 2005;2(11):851–56. PMID: 16278656. doi:10.1038/nmeth803.
   PubMed Web of Science ®Google Scholar
• Zhang L, Luo S, Zhang B. The use of lectin microarray for assessing glycosylation of therapeutic proteins. MAbs. 2016;8(3):524–35. doi:10.1080/19420862.2016.1149662.
   PubMed Web of Science ®Google Scholar
• Luo S, Zhang B. Benchmark glycan profile of therapeutic monoclonal antibodies produced by Mammalian Cell Expression Systems. Pharm Res. 2023: PMID: 37914842. doi:10.1007/s11095-023-03628-4.
   Web of Science ®Google Scholar
• Kobayashi Y, Tateno H, Dohra H, Moriwaki K, Miyoshi E, Hirabayashi J, Kawagishi H. A novel core fucose-specific lectin from the mushroom pholiota squarrosa. J Biol Chem. 2012;287:33973–82. PMID: 22872641. doi:10.1074/jbc.M111.327692.
   PubMed Web of Science ®Google Scholar
• Ichihara K, Arai S, Shimada S. cDNA cloning of a lectin-like gene preferentially expressed in freshwater from the macroalga ulva limnetica (ulvales, Chlorophyta). Phycol Res. 2009;57:104–10. doi:10.1111/j.1440-1835.2009.00526.x.
   Web of Science ®Google Scholar
• Tateno H, Winter HC, Goldstein IJ. Cloning, expression in Escherichia coli and characterization of the recombinant Neu5Acα2,6Galβ1,4GlcNAc-specific high-affinity lectin and its mutants from the mushroom polyporus squamosus. Biochem J. 2004;382(2):667–75. PMID: 15176950. doi:10.1042/bj20040391.
   PubMedGoogle Scholar
• Grahn E, Askarieh G, Holmner A, Tateno H, Winter HC, Goldstein IJ, Krengel U. Crystal structure of the Marasmius oreades mushroom lectin in complex with a xenotransplantation epitope. J Mol Biol. 2007;369(3):710–21. PMID: 17442345. doi:10.1016/j.jmb.2007.03.016.
   PubMed Web of Science ®Google Scholar
• Shah NJ, Kelly WJ, Liu SV, Choquette K, Spira A. Product review on the Anti-PD-L1 antibody atezolizumab. Hum Vaccin Immunother. 2018;14:269–276. doi:10.1080/21645515.2017.1403694.
   PubMed Web of Science ®Google Scholar
• Ayoub D, Jabs W, Resemann A, Evers W, Evans C, Main L, Baessmann C, Wagner-Rousset E, Suckau D, Beck A. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. MAbs. 2013;5(5):699–710. doi:10.4161/mabs.25423.
   PubMed Web of Science ®Google Scholar
• Hong J, Lee Y, Lee C, Eo S, Kim S, Lee N, Park J, Park S, Seo D, Jeong M. et al. Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). MAbs. 2017;9(2):365–83. doi:10.1080/19420862.2016.1264550.
   Web of Science ®Google Scholar
• Douez E, D’Atri V, Guillarme D, Antier D, Guerriaud M, Beck A, Watier H, Foucault-Fruchard L. Why is there no biosimilar of Erbitux®? J Pharm Biomed Anal. 2023;234:115544. PMID: 37418870. doi:10.1016/j.jpba.2023.115544.
   PubMed Web of Science ®Google Scholar
• Qian J, Liu T, Yang L, Daus A, Crowley R, Zhou Q. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal Biochem. 2007;364(1):8–18. PMID: 17362871. doi:10.1016/j.ab.2007.01.023.
   PubMed Web of Science ®Google Scholar
• Cowper B, Lavén M, Hakkarainen B, Mulugeta E. Glycan analysis of erythropoiesis-stimulating agents. J Pharmaceut Biomed. 2020;180:113031. doi:10.1016/j.jpba.2019.113031.
   PubMed Web of Science ®Google Scholar
• Cowper B, Li X, Yu L, Zhou Y, Fan WH, Rao CM. Comprehensive glycan analysis of twelve recombinant human erythropoietin preparations from manufacturers in China and Japan. J Pharmaceut Biomed. 2018;153:214–20. doi:10.1016/j.jpba.2018.02.043.
   PubMed Web of Science ®Google Scholar
• Chen C-H, Lin Y-P, Lin J-L, Li S-T, Ren C-T, Wu C-Y, Chen C-H. Rapid identification of terminal sialic acid linkage isomers by pseudo-MS3 Mass spectrometry. Isr J Chem. 2015;55(3–4):412–22. https://doi.org/10.1002/ijch.201400141.
   Web of Science ®Google Scholar
• Duivelshof BL, Murisier A, Camperi J, Fekete S, Beck A, Guillarme D, D’Atri V. Therapeutic fc-fusion proteins: Current analytical strategies. J Sep Sci. 2021;44:35–62. PMID: 32914936. doi:10.1002/jssc.202000765.
   PubMed Web of Science ®Google Scholar
• Largy E, Cantais F, Van Vyncht G, Beck A, Delobel A. Orthogonal liquid chromatography-mass spectrometry methods for the comprehensive characterization of therapeutic glycoproteins, from released glycans to intact protein level. J Chromatogr A. 2017;1498:128–46. PMID: 28372839. doi:10.1016/j.chroma.2017.02.072.
   PubMed Web of Science ®Google Scholar
• Sjögren J, Cosgrave EF, Allhorn M, Nordgren M, Björk S, Olsson F, Fredriksson S, Collin M. EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans. Glycobiology. 2015;25(10):1053–63. PMID: 26156869. doi: 10.1093/glycob/cwv047.
   PubMed Web of Science ®Google Scholar
• Jaffar-Aghaei M, Khanipour F, Maghsoudi A, Sarvestani R, Mohammadian M, Maleki M, Havasi F, Rahmani H, Karagah AH, Kazemali MR. QbD-guided pharmaceutical development of pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®. Eur J Pharm Sci. 2022;173:106171. PMID: 35378209. doi:10.1016/j.ejps.2022.106171.
   PubMed Web of Science ®Google Scholar
• De Leoz MLA, Duewer DL, Fung A, Liu L, Yau HK, Potter O, Staples GO, Furuki K, Frenkel R, Hu Y. et al. NIST interlaboratory study on glycosylation analysis of monoclonal antibodies: comparison of results from diverse analytical Methods*. Mol Cell Proteom. 2020;19(1):11–30. https://doi.org/10.1074/mcp.RA119.001677.
   PubMed Web of Science ®Google Scholar
• Duivelshof BL, Denorme S, Sandra K, Liu X, Beck A, Lauber MA, Guillarme D, D’Atri V. Quantitative N-Glycan profiling of therapeutic monoclonal antibodies performed by middle-up level HILIC-HRMS analysis. Pharmaceutics. 2021;13(11):1744. doi:10.3390/pharmaceutics13111744.
   PubMed Web of Science ®Google Scholar